Table 2 Patients' Characteristics According to Stage-modified IPI
Characteristics (adverse factors of all patients) | Number of patients (%) |
|---|---|
   Age > 60 years | 24 (28.9) |
   Serum LDH > 245 U/L | 40 (48.2) |
   ECOG Performance Status ≥ 2 | 9 (10.8) |
   Lugano stage ≥ II2 | 54 (65.1) |
   Extranodal site involvement (excluding stomach) ≥ 1 | 9 (10.8) |
Risk groups (number of risk factors) | Â |
   Low risk group (0-1) | 38 (45.8) |
   Intermediate risk group (2) | 26 (31.3) |
   High risk group (3-5) | 19 (22.9) |